This site requires flash 8 You currently do not have the necessary Macromedia Flash plug-in to view this page
Click here to download the Macromedia Flash plug-in
As TAPI we offer customized solutions through our rich portfolio of over 290 active pharmaceutical ingredients. One of our greatest strengths lies in our superior flexibility in tailoring the solid state specifications (i.e. PSD, bulk density) and polymorphic forms. Engaging the expertise of our scientists and technologists, our customer service professionals are dedicated to managing the specification process as well as fulfilling your service requests, such as providing analytical support and relevant regulatory and quality documentation, to meet your exact needs.
Credibility
Zero tolerance. That’s our quality commitment. Our generously staffed quality departments are evidence to the priority we place on ensuring compliance with your specifications as well as all relevant regulatory requirements, including current GMP standards, USP and EP among others. All of our plants are regularly inspected by the FDA, other authorities as well as by our customers. During 2008, The FDA performed 10 inspections at TAPI's production plants worldwide. At TAPI, quality is the cornerstone upon which we built our business.
Competency
At TAPI, our product expertise is focused on chemical synthesis, fermentation, high potency, plant extract, synthetic peptides, vitamin D derivatives and prostaglandins. Key to our success in providing solutions that are both efficient yet customized is our highly regarded expertise in solid state and analytical research and development. In particular, TAPI R&D has integrated the identification of the API’s polymorphic forms into our product development process.
Confidence
TAPI gives you the ingredients to operate with confidence. Our Intellectual Property (IP) leadership rests on over 4,500 registered and pending patents and is backed by a dedicated legal team that has repeatedly been successful at protecting our customers’ freedom to operate.
Continuity
Our priority investment in Research & Development is the fuel that enables TAPI to sustain its leadership position.
TAPI is first to market with new products and stays on last, committed to supplying each product as long as demand exists. That’s continuity you can rely on.
Capacity
TAPI operates 21 production facilities globally, as well as 7 development centers World-Wide with R&D force of over 600 scientists.
Our continuous investment and expansion of these facilities is a deliberate policy that enables us to deliver on our commitments to you.
